1. A genetic risk score predicts de novo hepatocellular carcinoma in hepatits c cirrhotic patients treated with direct-acting antivirals. (February 2020) Authors: Degasperi, E.; Galmozzi, E.; Pelusi, S.; D'Ambrosio, R.; Soffredini, R.; Borghi, M.; Perbellini, R.; Facchetti, F.; Iavarone, M.; Sangiovanni, A.; Valenti, L.; Lampertico, P. Journal: Digestive and liver disease Issue: Volume 52(2020)Supplement 1 Page Start: e19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AGT gene polymorphisms predict early dose modification of sorafenib for dermatological adverse events: towards tailored medicine for patients with hepatocellular carcinoma. (February 2019) Authors: Iavarone, M.; Galmozzi, E.; De Silvestri, A.; Casadei-Gardini, A.; Piscaglia, F.; Marisi, G.; Facchetti, F.; Faloppi, L.; Ielasi, L.; Tovoli, F.; Cimino, A.; Scartozzi, M.; Cascinu, S.; Sangiovanni, A.; Tinelli, C.; Lampertico, P. Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 1 Page Start: e38 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Baseline clinical features but not TLL1 variants predicts HCC onset in Caucasian compensated HBV cirrhotics treated by Entecavir or Tenofovir for 8 years. Issue 1 (February 2018) Authors: Loglio, A.; Galmozzi, E.; Iavarone, M.; Grossi, G.; Viganò, M.; Facchetti, F.; Perbellini, R.; Rumi, M.G.; Sangiovanni, A.; Lampertico, P. Journal: Digestive and liver disease Issue: Volume 50:Issue 1(2018)Supplement Page Start: 51 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Clinical but not genetic variables predict the development of hepatocellular carcinoma in hepatitis C cirrhotic patients treated with direct acting antivirals: a 3-year study in 509 patients. (February 2019) Authors: Degasperi, E.; Galmozzi, E.; Facchetti, F.; D'Ambrosio, R.; Soffredini, R.; Borghi, M.; Perbellini, R.; Iavarone, M.; Sangiovanni, A.; Lampertico, P. Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 1 Page Start: e67 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Genetic variants do not predict the development of hepatocellular carcinoma in cross-sectional and longitudinal studies including caucasian compensated hbv cirrhotics treated with nuc for 10 years. (February 2020) Authors: Galmozzi, E.; Loglio, A.; Facchetti, F.; Iavarone, M.; Borghi, M.; Viganò, M.; Perbellini, R.; Rumi, M.G.; Sangiovanni, A.; Lampertico, P. Journal: Digestive and liver disease Issue: Volume 52(2020)Supplement 1 Page Start: e25 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Genetic variations in PD-1 and STAT4 genes do not predict off-treatment functional cure in IFN treated genotype D, HBeAg-negative patients with chronic hepatitis B. Issue 1 (16th February 2017) Authors: Galmozzi, E.; Facchetti, F.; Grossi, G.; Loglio, A.; Lampertico, P. Journal: Digestive and liver disease Issue: Volume 49:Issue 1(2017)Supplement Page Start: e29 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. High rates of renal tubular damage in HBV monoinfected patients long-term treated with tenofovir: A cross-sectional, single center, real-life study in 414 patients. Issue 1 (16th February 2017) Authors: Grossi, G.; Loglio, A.; Facchetti, F.; Galmozzi, E.; Colombo, M.; Lampertico, P. Journal: Digestive and liver disease Issue: Volume 49:Issue 1(2017)Supplement Page Start: e9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. High‐resolution melting assay for genotyping of IFNL4‐associated dinucleotide variant rs368234815. (15th May 2014) Authors: Galmozzi, E.; Facchetti, F.; Perbellini, R.; Aghemo, A.; Antonelli, G. Journal: Clinical microbiology and infection Issue: Volume 20:Number 11(2014:Nov.) Page Start: O936 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. HLA DPB1 rs9277535 polymorphism strongly predicts HBsAg clearance in interferon treated genotype D HBeAg-negative patients with chronic hepatitis B. (15th February 2015) Authors: Lampertico, P.; Galmozzi, E.; Facchetti, F.; Cheroni, C.; Invernizzi, F.; Valveri, V.; Soffredini, R.; Viganò, M.; Abrignani, S.; De Francesco, R.; Colombo, M. Journal: Digestive and liver disease Issue: Volume 47(2015)Supplement 1 Page Start: e28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. IFNL4 polymorphisms predict sustained response and HBsAg clearance in interferon treated HBeAg negative chronic hepatitis B patients. (15th February 2015) Authors: Galmozzi, E.; Lampertico, P.; Facchetti, F.; Invernizzi, F.; Mangia, G.; Vigano, M.; Soffredini, R.; Colombo, M. Journal: Digestive and liver disease Issue: Volume 47(2015)Supplement 1 Page Start: e49 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗